The European Commission should shift funding towards smaller enterprises that cannot participate in Horizon 2020, says the European Parliament’s rapporteur on a new SME initiative
France’s small biopharmaceutical and life science companies have been weakened by the financial crisis and had to face a drastic drop in investment in 2009.
After the proposed Small Business Act, now it’s the turn of the European Commission’s wealthiest department – the regional policy directorate – to do its bit for SMEs.